U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C2H4NO2.Fe
Molecular Weight 203.962
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS BISGLYCINATE

SMILES

[Fe++].NCC([O-])=O.NCC([O-])=O

InChI

InChIKey=GIPOFCXYHMWROH-UHFFFAOYSA-L
InChI=1S/2C2H5NO2.Fe/c2*3-1-2(4)5;/h2*1,3H2,(H,4,5);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula C2H4NO2
Molecular Weight 74.0587
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Fe
Molecular Weight 55.845
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
PubMed

PubMed

TitleDatePubMed
[FERROUS ASPARTATE IN THERAPY].
1964 Jan 1
Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe.
1997 Oct
Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
2007
Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example.
2017 Jul 5
Patents

Sample Use Guides

Unknown
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:16:17 UTC 2023
Edited
by admin
on Fri Dec 15 17:16:17 UTC 2023
Record UNII
SFW1D987QV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FERROUS BISGLYCINATE
MI   VANDF   WHO-DD  
Common Name English
FERROUS GLYCINATE [FCC]
Common Name English
FERROUS GLYCINATE
FCC  
INCI  
Official Name English
FERROUS BISGLYCINATE [VANDF]
Common Name English
FERROUS GLYCINATE [INCI]
Common Name English
BIS(GLYCINATO-.KAPPA.N,.KAPPA.O)IRON
Systematic Name English
Ferrous bisglycinate [WHO-DD]
Common Name English
FERROUS BISGLYCINATE [MI]
Common Name English
IRON BIS-GLYCINATE
Common Name English
FERROCHEL
Brand Name English
BISGLYCINO-IRON(II) CHELATE
Common Name English
IRON BIS-GLYCINATE CHELATE
Common Name English
IRON(II) GLYCINATE
Systematic Name English
Code System Code Type Description
PUBCHEM
9837124
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
RXCUI
1102188
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY RxNorm
DAILYMED
SFW1D987QV
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
CAS
20150-34-9
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
GRAS Notification (GRN No.)
19
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
DRUG CENTRAL
5187
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
EPA CompTox
DTXSID30173978
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
MERCK INDEX
m5338
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY Merck Index
DRUG BANK
DB11210
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
SMS_ID
100000126286
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
FDA UNII
SFW1D987QV
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
EVMPD
SUB32941
Created by admin on Fri Dec 15 17:16:18 UTC 2023 , Edited by admin on Fri Dec 15 17:16:18 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
SALT/SOLVATE -> PARENT
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY